Genmab A (GMAB) Enterprise Value (2018 - 2026)
Genmab A (GMAB) posted Enterprise Value of -$1.5 billion for Q1 2026, up 11.31% on a QoQ basis from -$1.7 billion in Q4 2025, and up 10.48% year-over-year from -$1.4 billion in Q1 2025.
Genmab A (GMAB) Enterprise Value (2018 - 2026) Analysis & Trends
Genmab A's Enterprise Value history runs 7 years deep, the most recent figure standing at -$1.5 billion for Q1 2026.
- Quarterly Enterprise Value rose 10.48% year-over-year to -$1.5 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.5 billion (up 10.48% YoY) and the FY2025 annual result came in at -$1.7 billion, down 23.29% from the prior year.
- Enterprise Value was -$1.5 billion for Q1 2026 at Genmab A, up from -$1.7 billion in the prior quarter.
- Across five years, Enterprise Value topped out at -$2.0 million in Q2 2024 and bottomed at -$2.4 billion in Q4 2023.
- A 4-year average of -$1.2 billion and a median of -$1.5 billion in 2025 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2024 — Enterprise Value jumped 42.14% — and 2025, when it sank 70800.0%.
- Genmab A's Enterprise Value stood at -$2.4 billion in 2023, then jumped by 42.14% to -$1.4 billion in 2024, then dropped by 23.29% to -$1.7 billion in 2025, then climbed by 11.31% to -$1.5 billion in 2026.
- Business Quant data shows GMAB's Enterprise Value at -$1.5 billion in Q1 2026, -$1.7 billion in Q4 2025, and -$1.9 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | Genmab A | 1.89 Bn | 366.92 Mn | 831.00 Mn | -1.52 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.52 Bn |
| Dec 31, 2025 | -1.72 Bn |
| Sep 30, 2025 | -1.90 Bn |
| Jun 30, 2025 | -1.42 Bn |
| Mar 31, 2025 | -1.70 Bn |
| Dec 31, 2024 | -1.39 Bn |
| Sep 30, 2024 | -43.00 Mn |
| Jun 30, 2024 | -2.00 Mn |
| Mar 31, 2024 | -130.00 Mn |
| Dec 31, 2023 | -2.40 Bn |
| Sep 30, 2020 | -8,892,000.00 Bn |
| Dec 31, 2019 | -4,643.00 |
| Sep 30, 2019 | -4.64 Bn |
| Dec 31, 2018 | -896.07 Mn |